WANFANG MED ONLINE

Your Position: Home > Journal List > CHINESE JOURNAL OF OBSTETRICS AND GYNECOLOGY > Paper

Comparison of therapeutical effect between arterial interventional chemotherapy and venous chemotherapy on bulky or locally advanced cervical cancer

( views:, downloads: )

Author:: WANG Ping()
PENG Zhi-lan()
ZHANG Jia-wen()
LIU Hui()
ZHANG Chong-shu()
CAO Ze-yi()

Journal Title:: CHINESE JOURNAL OF OBSTETRICS AND GYNECOLOGY

Issue:: Volume 40, Issue 04, 2005

DOI:

Key Word:

Abstract：

Reference

[1]Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin,1999,49:33-64.
[2]张志毅,章文华,主编.现代妇科肿瘤外科学.北京:科学出版社,2003.240-241.
[3]Minagawa Y, Kigawa J, Irie T, et al. Radical surgery following neoadjuvant chemotherapy for patients with stage IIIB cervical cancer.Ann Surg Oncol,1998,5:539-543.
[4]Ivanov S, Zervudis S, Ivanov S. Metastatic cancer in transposed ovaries after radical Wertheim-Meigs hysterectomy for a stage I B and II A cervical cancer.Akush Ginekol (Sofiia),2003,42:22-24.
[5]Toita T, Mitsuhashi N, Teshima T, et al.Postoperative radiotherapy for uterine cervical cancer: results of the 1995-1997 patterns of care process survey in Japan.Jpn J Clin Oncol,2004,34:99-103.
[6]Frei E 3rd. Clinical cancer research: an embattled species. Cancer,1982, 50:1979-1992.
[7]Hwang YY, Moon H, Cho SH, et al. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy. Gynecol Oncol,2001, 82:88-93.
[8]Aoki Y, Sasaki M, Watanabe M, et al. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Gynecol Oncol,2000, 77:305-309.
[9]Yamada T, Ohsugi F, Irie T,et al. Extended intraarterial cisplatin infusion for treatment of gynecologic cancer after alteration of intrapelvic blood flow and implantation of a vascular access device. Cardiovasc Intervent Radiol,1996,19:139-145.
[10]Aoki Y, Tomita M, Sato T, et al. Neoadjuvant chemotherapy for patients younger than 50 years with high-risk squamous cell carcinoma of the cervix. Gynecol Oncol,2001,83:263-267.
[11]Adachi S, Ogasawara T, Tsubamoto H, et al. Intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical cancer. Int J Clin Pharmacol Res, 2001,21:105-110.
[12]Park DC, Kim JH, Lew YO, et al. Phase II trial of neoadjuvant paclitaxel and cisplatin in uterine cervical cancer. Gynecol Oncol,2004, 92:59-63.
[13]Mutch DG, Bloss JD. Gemcitabine in cervical cancer. Gynecol Oncol,2003,90:8-15.
[14]Vallejo CT, Machiavelli MR, Perez JE, et al. Docetaxel as neoadjuvant chemotherapy in patients with advanced cervical carcinoma. Am J Clin Oncol,2003,26:477-482.